• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素和催产素与人乳腺癌细胞的相互作用。

Interaction of vasopressin and oxytocin with human breast carcinoma cells.

作者信息

Taylor A H, Ang V T, Jenkins J S, Silverlight J J, Coombes R C, Luqmani Y A

机构信息

Division of Biochemical Medicine, St. George's Hospital Medical School, London, England.

出版信息

Cancer Res. 1990 Dec 15;50(24):7882-6.

PMID:2174737
Abstract

The arginine vasopressin and oxytocin content of normal and cancerous human breast tissue were measured using radioimmunoassay. Both peptides were present in amounts greater than that found in the circulation, but no difference between normal and malignant tissues was found. Binding of [3H]oxytocin and [3H]vasopressin were characterized in human breast carcinoma cells (MCF7 cells). Binding of both hormones to MCF7 cells was specific and saturable, the vasopressin receptor found to be of the V1 subtype. Scatchard analyses of the data were linear, indicating a single high affinity, low capacity binding site for each hormone (vasopressin: KD = 47.4 +/- 1.6 nmol/liter, Bmax = 27,300 +/- 6,500 sites/cell; oxytocin: KD = 51.3 +/- 0.4 nmol/liter, Bmax = 87,000 +/- 4,000 sites/cell). The effects of vasopressin and oxytocin on the growth of MCF7 cells were assessed using protein accumulation and cell numbers. Vasopressin at 10-1000 pmol/liter was mitogenic for MCF7 cells, but higher doses (10 nmol/liter) were growth inhibitory. Oxytocin was also mitogenic for MCF7 cells but to a lesser extent than vasopressin. In conclusion, we suggest that vasopressin and possibly oxytocin may be important modulators of the growth of some human breast carcinomas.

摘要

采用放射免疫分析法测定了正常和癌性人乳腺组织中精氨酸加压素和催产素的含量。两种肽的含量均高于循环中的含量,但未发现正常组织和恶性组织之间存在差异。对人乳腺癌细胞(MCF7细胞)中[3H]催产素和[3H]加压素的结合进行了表征。两种激素与MCF7细胞的结合均具有特异性和饱和性,发现加压素受体为V1亚型。对数据进行Scatchard分析呈线性,表明每种激素都有一个单一的高亲和力、低容量结合位点(加压素:KD = 47.4 +/- 1.6 nmol/升,Bmax = 27,300 +/- 6,500位点/细胞;催产素:KD = 51.3 +/- 0.4 nmol/升,Bmax = 87,000 +/- 4,000位点/细胞)。使用蛋白质积累和细胞数量评估了加压素和催产素对MCF7细胞生长的影响。10 - 1000 pmol/升的加压素对MCF7细胞有促有丝分裂作用,但更高剂量(10 nmol/升)具有生长抑制作用。催产素对MCF7细胞也有促有丝分裂作用,但程度低于加压素。总之,我们认为加压素以及可能的催产素可能是某些人乳腺癌生长的重要调节因子。

相似文献

1
Interaction of vasopressin and oxytocin with human breast carcinoma cells.血管加压素和催产素与人乳腺癌细胞的相互作用。
Cancer Res. 1990 Dec 15;50(24):7882-6.
2
Imprinting with oxytocin and vasopressin in Chang liver cell cultures: hormonal overlap, binding and influence on cell division.催产素和加压素在Chang肝细胞培养中的印记作用:激素重叠、结合及对细胞分裂的影响
Acta Physiol Hung. 1988;71(1):35-40.
3
Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.一种血管加压素拮抗剂与大鼠脑隔区血管加压素受体的相互作用。
Synapse. 1988;2(3):205-11. doi: 10.1002/syn.890020306.
4
Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.
Mol Pharmacol. 1987 Mar;31(3):259-66.
5
Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
Mol Pharmacol. 1988 Feb;33(2):218-24.
6
Oxytocin receptors in rat adenohypophysis: evidence from radioligand binding studies.
Endocrinology. 1986 Nov;119(5):2393-5. doi: 10.1210/endo-119-5-2393.
7
Oxytocin and vasopressin: distinct receptors in myometrium.催产素和加压素:子宫肌层中的不同受体。
J Clin Endocrinol Metab. 1987 Jun;64(6):1129-35. doi: 10.1210/jcem-64-6-1129.
8
Evidence of two steps in the homologous desensitization of vasopressin-sensitive phospholipase C in WRK1 cells. Uncoupling and loss of vasopressin receptors.WRK1细胞中血管加压素敏感性磷脂酶C同源脱敏过程中两个步骤的证据。血管加压素受体的解偶联和丧失。
J Biol Chem. 1988 Jul 25;263(21):10443-50.
9
Vasopressin receptors in human pregnant myometrium and decidua: interactions with oxytocin and vasopressin agonists and antagonists.人妊娠子宫肌层和蜕膜中的血管加压素受体:与催产素及血管加压素激动剂和拮抗剂的相互作用
Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1637-43. doi: 10.1016/0002-9378(89)90941-1.
10
Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.与激动剂缩宫素和卡贝缩宫素相比,选择性缩宫素受体拮抗剂巴芦米布的缩宫素受体结合结构域。
Eur J Pharmacol. 2005 Mar 7;510(1-2):9-16. doi: 10.1016/j.ejphar.2005.01.010.

引用本文的文献

1
Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers.应激调节激素与癌症:肾上腺素的作用及β受体阻滞剂的癌症治疗价值
Endocrine. 2025 May;88(2):359-386. doi: 10.1007/s12020-025-04161-7. Epub 2025 Jan 27.
2
High Oxytocin Receptor Expression Linked to Increased Cell Migration and Reduced Survival in Patients with Triple-Negative Breast Cancer.高催产素受体表达与三阴性乳腺癌患者细胞迁移增加和生存率降低有关。
Biomedicines. 2022 Jul 5;10(7):1595. doi: 10.3390/biomedicines10071595.
3
Conformational selection of vasopressin upon V receptor binding.
血管加压素与V受体结合时的构象选择
Comput Struct Biotechnol J. 2021 Oct 18;19:5826-5833. doi: 10.1016/j.csbj.2021.10.024. eCollection 2021.
4
Identification of oxytocin-related lncRNAs and assessment of their expression in breast cancer.鉴定与催产素相关的长链非编码 RNA 并评估其在乳腺癌中的表达。
Sci Rep. 2021 Mar 19;11(1):6471. doi: 10.1038/s41598-021-86097-2.
5
Insulin-Regulated Aminopeptidase in Women with Breast Cancer: A Role beyond the Regulation of Oxytocin and Vasopressin.乳腺癌女性中的胰岛素调节氨肽酶:超越催产素和加压素调节的作用
Cancers (Basel). 2020 Nov 4;12(11):3252. doi: 10.3390/cancers12113252.
6
Oxytocin receptor genetic alterations in hepatocellular carcinoma.肝细胞癌中催产素受体的基因改变
SN Compr Clin Med. 2019 Jul;1(7):523-526. doi: 10.1007/s42399-019-00085-2. Epub 2019 Jun 14.
7
The oxytocin receptor signalling system and breast cancer: a critical review.催产素受体信号系统与乳腺癌:批判性回顾。
Oncogene. 2020 Sep;39(37):5917-5932. doi: 10.1038/s41388-020-01415-8. Epub 2020 Aug 11.
8
Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.在胰腺癌患者中,催产素和催产素受体的改变、生存能力下降以及化疗耐药性增加。
Hepatobiliary Pancreat Dis Int. 2020 Apr;19(2):175-180. doi: 10.1016/j.hbpd.2019.12.002. Epub 2019 Dec 14.
9
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.靶向血管加压素 2 型受体治疗肾细胞癌。
Oncogene. 2020 Feb;39(6):1231-1245. doi: 10.1038/s41388-019-1059-0. Epub 2019 Oct 15.
10
Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line.促性腺激素释放激素对促肾上腺皮质激素腺瘤细胞系细胞增殖的影响。
Endocrinol Metab (Seoul). 2019 Sep;34(3):302-313. doi: 10.3803/EnM.2019.34.3.302.